Powell EE, Wong VW, Rinella M (2021) Non-alcoholic fatty liver disease. Lancet 397(10290):2212–2224

CAS  PubMed  Google Scholar 

Younossi ZM (2019) Non-alcoholic fatty liver disease–A global public health perspective. J Hepatol 70(3):531–544

PubMed  Google Scholar 

Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F et al (2019) Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 4(5):389–398

PubMed  Google Scholar 

Yang A, Zhu X, Zhang L, Ding Y (2024) Transitioning from NAFLD to MAFLD and MASLD: consistent prevalence and risk factors in a Chinese cohort. J Hepatol 80(4):e154–e155

PubMed  Google Scholar 

Zhang S, Gan S, Zhang Q, Liu L, Meng G, Yao Z, Wu H, Gu Y, Wang Y, Zhang T et al (2022) Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the Tianjin Chronic low-grade systemic inflammation and health cohort study. Int J Epidemiol 51(1):237–249

PubMed  Google Scholar 

Zhang S, Yan Y, Zeng XF, Gu Y, Wu H, Zhang Q, Liu L, Huo Z, Luo X, Zhang R, Sonestedt E (2025) Associations of the EAT-Lancet reference diet with metabolic dysfunction–associated steatotic liver disease and its severity: a multicohort study. Hepatology 81(5):1583–1594

PubMed  Google Scholar 

Arnold J, Idalsoaga F, Díaz LA, Cabrera D, Barrera F, Arab JP, Arrese M (2024) Emerging drug therapies for metabolic dysfunction-associated steatotic liver disease: a glimpse into the horizon. Current Hepatol Rep 23(1):204–219

Google Scholar 

Elkomy MH, Abo El-Ela FI, Zaki RM, Alsaidan OA, Elmowafy M, Zafar A, Shalaby K, Abdelgawad MA, Omar HA, Salama R et al (2023) Intranasal nanotransferosomal gel for quercetin brain targeting: II. Antidepressant effect in an experimental animal model. Pharmaceutics 15(8):2095

CAS  PubMed  PubMed Central  Google Scholar 

Anand David AV, Arulmoli R, Parasuraman S (2016) Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev 10(20):84–89

PubMed  PubMed Central  Google Scholar 

Chen L, Liu J, Mei G, Chen H, Peng S, Zhao Y, Yao P, Tang Y (2021) Quercetin and non-alcoholic fatty liver disease: a review based on experimental data and bioinformatic analysis. Food Chem Toxicol 154:112314

CAS  PubMed  Google Scholar 

Cao P, Wang Y, Zhang C, Sullivan MA, Chen W, Jing X, Yu H, Li F, Wang Q, Zhou Z et al (2023) Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy. J Nutr Biochem 120:109414

CAS  PubMed  Google Scholar 

Yao Z, Gu Y, Zhang Q, Liu L, Meng G, Wu H, Xia Y, Bao X, Shi H, Sun S et al (2019) Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults. Eur J Nutr 58(2):819–830

CAS  PubMed  Google Scholar 

Zhang S, Fu J, Zhang Q, Liu L, Meng G, Yao Z, Wu H, Bao X, Gu Y, Lu M et al (2019) Association between nut consumption and non-alcoholic fatty liver disease in adults. Liver Int 39(9):1732–1741

CAS  PubMed  Google Scholar 

Gu Y, Li H, Bao X, Zhang Q, Liu L, Meng G, Wu H, Du H, Shi H, Xia Y et al (2016) The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects. J Clin Endocrinol Metab 102(2):434–442

Google Scholar 

Farrell GC, Chitturi S, Lau GK, Sollano JD (2007) Asia-Pacific Working Party on N: guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 22(6):775–777

PubMed  Google Scholar 

Zhang S, Gu Y, Wang L, Zhang Q, Liu L, Lu M, Meng G, Yao Z, Wu H, Xia Y et al (2019) Association between dietary raw garlic intake and newly diagnosed nonalcoholic fatty liver disease: a population-based study. Eur J Endocrinol 181(6):591–602

CAS  PubMed  Google Scholar 

Xiao ML, Chen GD, Zeng FF, Qiu R, Shi WQ, Lin JS, Cao Y, Li HB, Ling WH, Chen YM (2019) Higher serum carotenoids associated with improvement of non-alcoholic fatty liver disease in adults: a prospective study. Eur J Nutr 58(2):721–730

CAS  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78(6):1966–1986

PubMed  Google Scholar 

Y Y (2018) China food composition tables. Standard Edition. Beijing: Peking University Medical Press.

Yao Z, Dai K, Meng G, Zhang Q, Liu L, Wu H, Gu Y, Sun S, Wang X, Jia Q et al (2021) Low dietary quercetin intake by food frequency questionnaire analysis is not associated with hypertension occurrence. Clin Nutr 40(6):3748–3753

CAS  PubMed  Google Scholar 

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252

CAS  PubMed  Google Scholar 

Macfarlane D, Chan A, Cerin E (2011) Examining the validity and reliability of the Chinese version of the international physical activity questionnaire, long form (IPAQ-LC). Public Health Nutr 14(3):443–450

PubMed  Google Scholar 

Yu B, Yu F, Su Q, Zhang Q, Liu L, Meng G, Wu H, Xia Y, Bao X, Shi H et al (2018) A J-shaped association between soy food intake and depressive symptoms in Chinese adults. Clin Nutr 37(3):1013–1018

CAS  PubMed  Google Scholar 

Hagstrom H, Adams LA, Allen AM, Byrne CD, Chang Y, Gronbaek H, Ismail M, Jepsen P, Kanwal F, Kramer J et al (2021) Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement. Hepatology 74(1):474–482

PubMed  Google Scholar 

Hayes-Larson E, Kezios KL, Mooney SJ, Lovasi G (2019) Who is in this study, anyway? Guidelines for a useful Table 1. J Clin Epidemiol 114:125–132

PubMed  PubMed Central  Google Scholar 

Li R, Chambless L (2007) Test for additive interaction in proportional hazards models. Ann Epidemiol 17(3):227–236

PubMed  Google Scholar 

Sotiropoulou M, Katsaros I, Vailas M, Lidoriki I, Papatheodoridis GV, Kostomitsopoulos NG, Valsami G, Tsaroucha A, Schizas D (2021) Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications. Saudi J Gastroenterol 27(6):319–330

PubMed  PubMed Central  Google Scholar 

Zhao X, Wang J, Deng Y, Liao L, Zhou M, Peng C, Li Y (2021) Quercetin as a protective agent for liver diseases: a comprehensive descriptive review of the molecular mechanism. Phytotherapy Res 35(9):4727–4747

CAS  Google Scholar 

Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A (2020) Importance of systematic reviews and meta-analyses of animal studies: challenges for animal-to-human translation. J Am Assoc Lab Anim Sci 59(5):469–477

PubMed  PubMed Central  Google Scholar 

Li N, Cui C, Xu J, Mi M, Wang J, Qin Y (2024) Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover clinical trial. Am J Clin Nutrit 120(3):507–517

CAS  PubMed  Google Scholar 

Pasdar Y, Oubari F, Zarif MN, Abbasi M, Pourmahmoudi A, Hosseinikia M (2020) Effects of quercetin supplementation on hematological parameters in non-alcoholic fatty liver disease: a randomized, double-blind. Placebo-Controlled Pilot Study Clin Nutr Res 9(1):11–19

PubMed  Google Scholar 

Zheng H, Sechi LA, Navarese EP, Casu G, Vidili G (2024) Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review. Cardiovasc Diabetol 23(1):346

PubMed  PubMed Central  Google Scholar 

Markowska J, Kasprzak-Drozd K, Niziński P, Dragan M, Kondracka A, Gondek E, Oniszczuk T, Oniszczuk A (2024) Quercetin: a promising candidate for the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Molecules 29(22):5245

CAS  PubMed  PubMed Central  Google Scholar 

Katsaros I, Sotiropoulou M, Vailas M, Kapetanakis EI, Valsami G, Tsaroucha A, Schizas D (2024) Quercetin’s potential in MASLD: investigating the role of autophagy and key molecular pathways in liver steatosis and inflammation. Nutrients 16(22):3789

CAS  PubMed  PubMed Central  Google Scholar 

Kashino Y, Murota K, Matsuda N, Tomotake M, Hamano T, Mukai R, Terao J (2015) Effect of processed onions on the plasma concentration of quercetin in rats and humans. J Food Sci 80(11):H2597-2602

CAS  PubMed  Google Scholar